Brief: Kamada Says Will Now Continue To Produce Glassia For Takeda Through 2021

Kamada

03/09/2019 12:15

Sept 3 (Reuters) - Kamada Ltd  KMDA.TA :
    * KAMADA ANNOUNCES EXTENSION OF GLASSIA® [ALPHA1-PROTEINASE
INHIBITOR (HUMAN)] SUPPLY AND DISTRIBUTION AGREEMENT WITH TAKEDA
THROUGH 2021 AND EXPECTED TRANSITION OF GLASSIA MANUFACTURING TO
TAKEDA
    * KAMADA LTD - KAMADA WILL NOW CONTINUE TO PRODUCE GLASSIA
FOR
TAKEDA THROUGH 2021
    * KAMADA LTD - PROJECTS TOTAL REVENUES FROM SALES OF GLASSIA
TO
TAKEDA DURING YEARS 2019-2021 WILL BE IN RANGE OF $155 MILLION
TO $180 MILLION
    * KAMADA LTD - REITERATING ITS FULL-YEAR 2019 REVENUE
GUIDANCE OF
$125 MILLION TO $130 MILLION
    * KAMADA LTD - PLANS TO PROVIDE ITS 2020 REVENUE GUIDANCE BY
END
OF 2019

Source text for Eikon:  ID:nGNX9rdL2J 
Further company coverage:  KMDA.TA 

 (Reuters.Briefs@thomsonreuters.com)